SOD1 and sarcopenia: For this reason, the team used genetic engineering to prepare Sod1-/- mouse models that exhibit many of the pathological features of aging at approximately 8 months of age, such as loss of muscle mass and strength, loss of skeletal muscle innervation, and increased skeletal muscle protein catabolism, which can be used to study aging-related sarcopenia and osteoporosis.